Omega 3 Fatty Acids in Bipolar Disorder | Zendy

Andrew L. Stoll | Zendy; W. Emanuel Severus | Zendy; Marlene P. Freeman | Zendy; Stephanie Rueter | Zendy; Holly A. Zboyan | Zendy; Eli L. Diamond | Zendy; Kimberly Cress | Zendy; Lauren B. Marangell | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Omega 3 Fatty Acids in Bipolar Disorder

Author(s) -

Andrew L. Stoll,

W. Emanuel Severus,

Marlene P. Freeman,

Stephanie Rueter,

Holly A. Zboyan,

Eli L. Diamond,

Kimberly Cress,

Lauren B. Marangell

Publication year - 1999

Publication title -

archives of general psychiatry

Language(s) - English

Resource type - Journals

eISSN - 1538-3636

pISSN - 0003-990X

DOI - 10.1001/archpsyc.56.5.407

Subject(s) - bipolar disorder , placebo , mood , medicine , fatty acid , lithium (medication) , mood disorders , cohort , placebo group , chemistry , psychology , endocrinology , psychiatry , biochemistry , anxiety , alternative medicine , pathology

Omega3 fatty acids may inhibit neuronal signal transduction pathways in a manner similar to that of lithium carbonate and valproate, 2 effective treatments for bipolar disorder. The present study was performed to examine whether omega3 fatty acids also exhibit mood-stabilizing properties in bipolar disorder.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research